Activation of T Lymphocytes with Anti‐PDL1‐BiTE in the Presence of Adipose‐Derived Mesenchymal Stem Cells (ASCs)
L Moeinzadeh, A Ramezani… - BioMed Research …, 2023 - Wiley Online Library
Background. Due to their ability to recruit immune cells to kill tumor cells directly, bispecific T
cell engager antibodies (BiTE) hold great potential in T cell redirecting therapies. BiTE is …
cell engager antibodies (BiTE) hold great potential in T cell redirecting therapies. BiTE is …
Activation of T Lymphocytes with Anti-PDL1-BiTE in the Presence of Adipose-Derived Mesenchymal Stem Cells (ASCs).
L Moeinzadeh, A Ramezani… - BioMed Research …, 2023 - search.ebscohost.com
Background. Due to their ability to recruit immune cells to kill tumor cells directly, bispecific T
cell engager antibodies (BiTE) hold great potential in T cell redirecting therapies. BiTE is …
cell engager antibodies (BiTE) hold great potential in T cell redirecting therapies. BiTE is …